Page 948 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 948

CHaPter 67  Autoimmune Peripheral Neuropathies                 915


           27.  Ilyas AA, Quarles RH, McIntosh TD, et al. IgM in a human neuropathy   35.  D’Souza A, Lacy M, Gertz M, et al. Long-term outcomes after autologous
             related to paraproteinemia binds to a carbohydrate determinant in the   stem cell transplantation for patients with POEMS syndrome
             myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci   (osteosclerotic myeloma): a single-center experience. Blood
             USA 1984;81:1225–9.                                    2012;120:56–62.
           28.  Ilyas AA, Quarles RH, Dalakas MC, et al. Polyneuropathy with   36.  Muppidi S, Vernino S. Paraneoplastic neuropathies. Continuum
             monoclonal gammopathy: glycolipids are frequently antigens for IgM   (Minneap Minn) 2014;20:1359–72.
             paraproteins. Proc Natl Acad Sci USA 1985;82:6697–700.  37.  Lennon VA, Ermilov LG, Szurszewski JH, et al. Immunization with
           29.  Lombardi R, Erne B, Lauria G, et al. IgM deposits on skin nerves in   neuronal nicotinic acetylcholine receptor induces neurological
             anti-myelin-associated glycoprotein neuropathy. Ann Neurol   autoimmune disease. J Clin Invest 2003;111:907–13.
             2005;57:180–7.                                       38.  Dalakas MC, Pezeshkpour GH. Neuromuscular diseases associated
           30.  Willison HJ, Trapp BD, Bacher JD, et al. Demyelination induced by   with human immunodeficiency virus infection. Ann Neurol
             intraneural injection of human antimyelin associated glycoprotein   1988;23:38–48.
             antibodies. Muscle Nerve 1988;11:1169–76.            39.  Hughes RA, Donofrio P, Bril V, et al. Intravenous immune globulin (10%
           31.  Tatum AH. Experimental paraprotein neuropathy; demyelination by   caprylate-chromatography purified) for the treatment of chronic
             passive transfer of human IgM anti-MAG. Ann Neurol 1993;33:502–6.  inflammatory demyelinating polyradiculoneuropathy (ICE study): a
           32.  Ilyas AA, Gu Y, Dalakas MC, et al. Induction of experimental ataxic   randomised placebo-controlled trial. Lancet Neurol 2008;7:136–44.
             sensory neuronopathy in cats by immunization with purified SGPG. J   40.  Dalakas MC, Quarles RH, Farrer RG, et al. A controlled study of
             Neuroimmunol 2008;193:87–93.                           intravenous immunoglobulin in demyelinating neuropathy with IgM
           33.  Leger JM, Guimaraes-Costa R, Muntean C. Immunotherapy in peripheral   gammopathy. Ann Neurol 1996;40:792–5.
             neuropathies. Neurother 2016;13:96–107.              41.  Dalakas MC, Rakocevic G, Salajegheh M, et al. Placebo-controlled trial of
           34.  Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions   rituximab in IgM anti-myelin associated glycoprotein antibody
             and long-term outcome. Blood 2003;101:2496–506.        demyelinating neuropathy. Ann Neurol 2009;65:286–93.
   943   944   945   946   947   948   949   950   951   952   953